1. Yanai, R., and Nagasawa, H. Inhibition of mammary tumorigenesis by-ergot alkaloids and promotion of mammary tumorigenesis by pituitary isografts in adreno-ovariectomized mice. J. Natl. Cancer Inst., 48: 715–719, 1972.
2. Floss, H.G., Cassady, J.M., and Robbers, J.E. Influence of ergot alkaloids on pituitary prolactin and prolactin-dependent processes. J. Pharm. Sci., 62: 699–715, 1973.
3. Sinha, Y.N., Selby, F.W., and Vanderlaan, W.P. Effects of ergot drugs on prolactin and growth hormone secretion, and on mammary nucleic acid content in C3H/Bi mice. J. Natl. Cancer Inst., 52: 189–191, 1974.
4. Yanai, R., and Nagasawa, H. Effect of 2-Br-α-ergocryptine on pituitary synthesis and release of prolactin and growth hormone in rats. Hormone Res., 5: 1–5, 1974.
5. Yanai, R., and Nagasawa, H. Suppression of mammary hyperplastic nodule formation and pituitary prolactin secretion in mice induced by ergocornine or 2-bromo-α-ergocryptine. J. Natl. Cancer Inst., 45: 1105–1112, 1970.